Posts In:

Inside TRIAD

Thin Line Abstract Shapes in the background with a circle that has a group of big dog graphics in the middle. With the TRIAD logo on the right bottom corner (dog outline with a heart on the chest and an atom as a brain)

Inside TRIAD: A Closer Look a the TRIAD Cohort

Published on October 28, 2024

The TRIAD clinical trial is a nationwide, double-blind veterinary clinical trial. This means half the dogs will receive the medication under study, and half will receive a placebo. In this trial, we will study the effects of the medication rapamycin.

Read More
Dog outline with heart and atom as a brain

Inside TRIAD: A Deeper Dive into the Test of Rapamycin In Aging Dogs

Published on October 24, 2024

In the TRIAD study, we hope to evaluate the safety, efficacy, and potential side effects of rapamycin in dogs, leading to improved veterinary care of senior dogs and contributions to the understanding of human aging.

Read More

Inside TRIAD: Introducing the Test of Rapamycin in Aging Dogs

Published on September 20, 2023

Many of the insights the Dog Aging Project gathers are through its surveys and activities; however, we also gain valuable information from the veterinary electronic medical records (VEMRs) that we receive. Submission of a VEMR is not necessary to enroll in the Dog Aging Project longitudinal observational study, but some of our smaller cohorts like Precision and TRIAD do require eligible VEMRs for consideration.

Read More